学术探索
学术期刊
新闻热点
数据分析
智能评审

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations (vol 154, pg 602, 2011)

被引：8
作者：
Bennett, Wendy L. [1 ]
Bass, Eric B. [1 ]
Bolen, Shari [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2011年 / 155卷 / 01期
关键词：
METFORMIN; ROSIGLITAZONE; MELLITUS; THERAPY;
D O I：
10.7326/0003-4819-155-1-201107050-00016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：67 / +
页数：2
相关论文
共 8 条
  • [1] Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study
    Bailey, CJ
    Bagdonas, A
    Rubes, J
    McMorn, SO
    Donaldson, J
    Biswas, N
    Stewart, MW
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (10) : 1548 - 1561
  • [2] Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
    Bennett, Wendy L.
    Maruthur, Nisa M.
    Singh, Sonal
    Segal, Jodi B.
    Wilson, Lisa M.
    Chatterjee, Ranee
    Marinopoulos, Spyridon S.
    Puhan, Milo A.
    Ranasinghe, Padmini
    Block, Lauren
    Nicholson, Wanda K.
    Hutfless, Susan
    Bass, Eric B.
    Bolen, Shari
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) : 602 - 613
  • [3] Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
    Fonseca, V
    Rosenstock, J
    Patwardhan, R
    Salzman, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1695 - 1702
  • [4] Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes
    Gómez-Perez, FJ
    Fanghänel-Salmón, G
    Barbosa, JA
    Montes-Villarreal, J
    Berry, RA
    Warsi, G
    Gould, EM
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (02) : 127 - 134
  • [5] Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes
    Jones, TA
    Sautter, M
    Van Gaal, LF
    Jones, NP
    [J]. DIABETES OBESITY & METABOLISM, 2003, 5 (03) : 163 - 170
  • [6] Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Biswas, N.
    Chou, H.
    Garber, A.
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (06) : 650 - 660
  • [7] Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes
    Stewart, M. W.
    Cirkel, D. T.
    Furuseth, K.
    Donaldson, J.
    Biswas, N.
    Starkie, M. G.
    Phenekos, C.
    Hamann, A.
    [J]. DIABETIC MEDICINE, 2006, 23 (10) : 1069 - 1078
  • [8] Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study
    Weissman, P
    Goldstein, BJ
    Rosenstock, J
    Waterhouse, B
    Cobitz, AR
    Wooddell, MJ
    Strow, LJ
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 2029 - 2035
1